对于抗治疗抑郁症而言,迷幻药的治疗潜力:现实还是幻觉? 一个系统的审查
Natia Horato1, Felipe Dalvi-Garcia, Pablo E P Dutra
1Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Journal of clinical psychopharmacology
|January 12, 2026
概括
迷幻药在治疗耐治疗抑郁症 (TRD) 中表现有前途,为治疗提供了一条新的治疗途径. 这一系统性审查综合了关于它们对TRD症状有效性的证据.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 耐治疗抑郁症 (TRD) 由于其严重程度和功能障碍,在精神卫生保健中构成了重大挑战.
- 现有的重大抑郁障碍 (MDD) 治疗方法对于TRD患者来说通常是不够的.
- 新兴研究表明,迷幻药可能迅速缓解抑郁症状.
研究的目的:
- 系统地审查和综合有关心理药物在治疗TRD中的疗效的科学证据.
- 为TRD提供目前关于迷幻药物的研究概述.
主要方法:
- 包括的研究集中在被诊断为TRD的参与者身上.
- 抑郁症的严重程度使用标准化尺度进行评估.
- 分析了随机对照试验 (RCT) 和开放标签研究.
主要成果:
- 包括15篇文章,10个RCT和5个开放标签试验.
- 该评论分析了关于典型和非典型迷幻药物的数据.
- 有证据表明,各种类型的迷幻药具有潜在的治疗益处.
结论:
- 迷幻药物代表了TRD的潜在替代和补充治疗方法.
- 这些发现支持对治疗耐药抑郁症的迷幻药的调查.
- 需要进一步的研究来确定TRD的最佳迷幻治疗方案.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
791
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
791
Psychosis: Goals of Pharmacotherapy
457
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
457
Electroconvulsive Therapy
841
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
841
Drug Therapy
237
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
237
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K


